Navigo Proteins

Navigo Proteins is a privately held protein engineering company specializing in the development of non-antibody binding proteins. Its core technology involves engineering highly stable, small scaffold proteins (like its Precision X® and Affilin® molecules) for two distinct applications: as custom affinity ligands for purifying biologics and as targeting modules for novel therapeutics and diagnostics. The company partners with pharmaceutical and biotech firms, positioning itself as a technology enabler for both manufacturing and drug development. With a focus on robotics-assisted selection and a specialist team, Navigo aims to provide robust, cost-effective solutions for the biopharmaceutical industry.

Proprietary protein engineering of non-immunoglobulin scaffolds (Precision X® and Affilin® molecules) using robotics-assisted selection and screening platforms to create custom affinity ligands for bioprocessing and targeted therapeutics.

Navigo competes in the alternative protein scaffold space against public companies like Ablynx/Sanofi (Nanobodies) and Molecular Partners (DARPins). In the affinity purification niche, it competes with chromatography resin giants (Cytiva, Thermo Fisher) offering platform solutions and other niche ligand developers. Its differentiation lies in the dual application of its engineered scaffolds across both manufacturing and therapeutics.